Keywords: کلوفارابین; Clofarabine; Lenalidomide; Immune profiling;
مقالات ISI کلوفارابین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: کلوفارابین; Acute myeloid leukemia; Hematopoietic stem cell transplantation; Clofarabine; Comorbidity;
Keywords: کلوفارابین; Circadian rhythm; Clofarabine; Pharmacokinetics; Toxicity
Keywords: کلوفارابین; Second; Transplantation; Leukemia; Clofarabine;
Keywords: کلوفارابین; Acute myeloid leukemia; Myelodysplastic syndromes; Clofarabine; Cytarabine;
Keywords: کلوفارابین; Clofarabine; Adults; Acute myeloid leukemia (AML)
Keywords: کلوفارابین; Elderly; AML; Clofarabine; Daunorubicin; Clinical trial;
Keywords: کلوفارابین; AML; ALL; Cladribine; 2-CdA; Clofarabine; Fludarabine; Forodesine; Nelarabine; Purine nucleoside analogs;
A Comparison of Clofarabine-based (GCLAC) and Cladribine-based (CLAG) Salvage Chemotherapy for Relapsed/Refractory AML
Keywords: کلوفارابین; AML; Cladribine; Clofarabine; GCSF; Relapsed/refractory;
Langerhans cell histiocytosis in children
Keywords: کلوفارابین; BRAF; cladribine; clofarabine; cytarabine; diabetes insipidus; Langerhans cell histiocytosis; steroids; vinblastine;
Discovery of novel purine nucleoside derivatives as phosphodiesterase 2 (PDE2) inhibitors: Structure-based virtual screening, optimization and biological evaluation
Keywords: کلوفارابین; Clofarabine; PDE2; Inhibitors; Purine nucleoside derivatives; Virtual screening;
Simultaneous quantification of busulfan, clofarabine and F-ARA-A using isotope labelled standards and standard addition in plasma by LC-MS/MS for exposure monitoring in hematopoietic cell transplantation conditioning
Keywords: کلوفارابین; Busulfan; Clofarabine; Fludarabine; LC-MS/MS; Standard addition;
Do cytogenetics affect the post-remission strategy for older patients with AML in CR1?
Keywords: کلوفارابین; Acute myeloid leukemia; Age; AML; Azacitidine; Clofarabine; Consolidation; CPX-351; Cytarabine; Cytogenetics; Daunorubicin; Decitabine; Minimal residual disease; MRD; Reduced intensity conditioning; RIC; Risk; TP53; Transplant;
Phase I Study of Clofarabine and 2-Gy Total Body Irradiation as a Nonmyeloablative Preparative Regimen for Hematopoietic Stem Cell Transplantation in Pediatric Patients with Hematologic Malignancies: A Therapeutic Advances in Childhood Leukemia Consortium
Keywords: کلوفارابین; Clofarabine; Hematopoietic stem cell transplantation; Nonmyeloablative;
Determination and quantification of intracellular fludarabine triphosphate, cladribine triphosphate and clofarabine triphosphate by LC-MS/MS in human cancer cells
Keywords: کلوفارابین; LC-MS/MS; Nucleoside 5â²-triphosphate; Cladribine; Fludarabine; Clofarabine; 2â²-Deoxyadenosine 5â² -triphosphate;
How can one optimize induction therapy in AML?
Keywords: کلوفارابین; Acute myeloid leukemia; AML; Ara-C; Azacitidine; Induction; Cladribine; Clofarabine; CPX-351; Cytarabine; Daunorubicin; Etoposide; Fludarabine; Gemtuzumab ozogamicin; Idarubicin; Vadastuximab talirine;
Interaction of anticancer drug clofarabine with human serum albumin and human α-1 acid glycoprotein. Spectroscopic and molecular docking approach
Keywords: کلوفارابین; Human serum α-1 acid glycoprotein; Human serum albumin; Fluorescence quenching; Circular dichroism; Molecular docking; Anticancer; Clofarabine;
Simultaneous determination of clofarabine and cytarabine in human plasma by LC-MS/MS
Keywords: کلوفارابین; AML; acute myeloid leukemia; ALL; acute lymphoid leukemia; CFB; clofarabine; CLARA; chemotherapy regimen with clofarabine 40Â mg/m2 and cytarabine 1000Â mg/m2; CTB; cytarabine; ESI; electrospray ionisation; HSCT; hematopoietic stem cell transplantation; I
Clofarabine Plus Low-Dose Cytarabine Is as Effective as and Less Toxic Than Intensive Chemotherapy in Elderly AML Patients
Keywords: کلوفارابین; Acute myeloid leukemia; Clofarabine; Induction therapy; Intensive chemotherapy; Propensity matching;
Long-Term Outcomes after Treatment with Clofarabineâ±âFludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic Syndrome
Keywords: کلوفارابین; Conditioning regimen; Clofarabine; Busulfan; Fludarabine; Allogeneic stem cell transplantation;
Phase I trial of low-dose oral Clofarabine in myelodysplastic syndromes patients who have failed frontline therapy
Keywords: کلوفارابین; Myelodysplasia; Clofarabine; Myelodysplastic syndrome
Phase I/II Study of Clofarabine, Etoposide, and Mitoxantrone in Patients With Refractory or Relapsed Acute Leukemia
Keywords: کلوفارابین; Acute myeloid leukemia; Adult; Clofarabine; Relapse; Refractory;
Sorafenib As Monotherapy or in Association With Cytarabine and Clofarabine for the Treatment of Relapsed/Refractory FLT3 ITD-Positive Advanced Acute Myeloid Leukemia
Keywords: کلوفارابین; Acute myeloid leukemia; Clofarabine; FLT3 mutation; FLT3 inhibitors; Sorafenib;
A sensitive LC-MS/MS method for quantifying clofarabine triphosphate concentrations in human peripheral blood mononuclear cells
Keywords: کلوفارابین; Clofarabine; Clofarabine triphosphate; Liquid chromatography-tandem mass spectrometry; Peripheral blood mononuclear cells;
Simultaneous determination of fludarabine and clofarabine in human plasma by LC-MS/MS
Keywords: کلوفارابین; Fludarabine; Clofarabine; LC-MS/MS; Plasma;
Phase I and Extension Study of Clofarabine Plus Cyclophosphamide in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
Keywords: کلوفارابین; ALL; Clofarabine; Salvage chemotherapy
Resveratrol contributes to chemosensitivity of malignant mesothelioma cells with activation of p53
Keywords: کلوفارابین; Resveratrol; Clofarabine; Mesothelioma; Apoptosis; p53; Chemopotentiator; MM; malignant mesothelioma; p-p53; phospho-p53; MTT; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolum bromide; HRP; horseradish peroxidase; ECL; enhanced chemiluminescence; DAPI
Synergistic Cytotoxicity of Sorafenib with Busulfan and Nucleoside Analogs in Human FMS-like Tyrosine Kinase 3 Internal Tandem Duplications–Positive Acute Myeloid Leukemia Cells
Keywords: کلوفارابین; Sorafenib; Acute myeloid leukemia; FLT3; Busulfan; Clofarabine; Fludarabine
Clofarabine, a novel adenosine analogue, reactivates DNA methylation-silenced tumour suppressor genes and inhibits cell growth in breast cancer cells
Keywords: کلوفارابین; Clofarabine; Epigenetic therapy; Tumour suppressor genes; Promoter methylation; Breast cancer
Synthesis and in vitro cytostatic activity of 1,2- and 1,3-diacylglycerophosphates of clofarabine
Keywords: کلوفارابین; Clofarabine; Prodrugs; Phosphoramidite approach; 1,2-, 1,3-Diacylglycerophospholipids; Antitumor activity;
Epstein-Barr Virus-Induced CD30-Positive Diffuse Large B-Cell Lymphoma in a Patient With Mixed-Phenotypic Leukemia Treated With Clofarabine
Keywords: کلوفارابین; Clofarabine; Diffuse large cell lymphoma; Epstein-Barr Virus; Mixed phenotype leukemia;
Clofarabine Does Not Negatively Impact the Outcomes of Patients With Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation
Keywords: کلوفارابین; Acute myeloid leukemia; Allogeneic stem cell transplantation; Clofarabine; Hepatotoxicity; Venoocclusive disease
New agents: Great expectations not realized
Keywords: کلوفارابین; acute myeloid leukemia, AML; CPX-351; FLAM; flavopiridol; FLT3 inhibitor; gemtuzumab; tipifarnib; lintuzumab; laromustine; lestaurtinib; midostaurin; AC220; clofarabine; quizartinib; sapacitabine
Nucleoside analogue electrochemical behaviour and in situ evaluation of DNA–clofarabine interaction
Keywords: کلوفارابین; Clofarabine; DNA; Oxidation; Voltammetry
Synergism between clofarabine and decitabine through p53R2: A pharmacodynamic drug-drug interaction modeling
Keywords: کلوفارابین; AML; acute myeloid leukemia; PD; pharmacodynamic; IC50; concentration achieving 50% inhibition of cell growth; Emax; maximal response; gamma (γ); measure of the steepness of slope; psi (Ψ); interaction term; Clofarabine; Decitabine; AML; Synergy; Pharma
Phase I-II Study of Clofarabine-Melphalan-Alemtuzumab Conditioning for Allogeneic Hematopoietic Cell Transplantation
Keywords: کلوفارابین; Clofarabine; Conditioning; Phase II; Transplant
A Phase I Trial of High-Dose Clofarabine, Etoposide, and Cyclophosphamide and Autologous Peripheral Blood Stem Cell Transplantation in Patients with Primary Refractory and Relapsed and Refractory Non-Hodgkin Lymphoma
Keywords: کلوفارابین; Autologous stem cell transplantation; Clofarabine; non-Hodgkins lymphoma
Clofarabine ± Fludarabine with Once Daily i.v. Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and MDS
Keywords: کلوفارابین; Clofarabine; Fludarabine; IV Busulfan; CML; AML; MDS; Allogeneic; Stem Cell Transplantation
The synergistic cytotoxicity of clofarabine, fludarabine and busulfan in AML cells involves ATM pathway activation and chromatin remodeling
Keywords: کلوفارابین; Clofarabine; Fludarabine; Busulfan; Synergistic cytotoxicity; Chromatin remodeling
Has there been progress in the treatment of older patients with acute myeloid leukemia?
Keywords: کلوفارابین; acute myeloid leukemia; AML; older; elderly; intensive; age; performance status; karyotype; molecular; gemtuzumab ozogamicin; azacitidine; decitabine; clofarabine; transplantation
Are we nearer to curing patients with MDS?
Keywords: کلوفارابین; myelodysplastic syndromes, MDS; epidemiology; International Prognostic Scoring System, IPSS; erythropoiesis-stimulating agents, ESAs; lenalidomide; hypomethylating agent; DNA methyltransferase inhibitor; decitabine; azacitidine; clofarabine;
Renal excretion of clofarabine: Assessment of dose-linearity and role of renal transport systems on drug excretion
Keywords: کلوفارابین; Clofarabine; Isolated perfused rat kidney; Renal excretion; Transporters
Novel Therapies for Myelodysplastic Syndromes
Keywords: کلوفارابین; Myelodysplastic syndromes; Histone deacetylase inhibitors; Clofarabine; Ezatiostat; Farnesyltransferase inhibitors; Laromustine;
Clofarabine induces hypomethylation of DNA and expression of Cancer-Testis antigens
Keywords: کلوفارابین; Clofarabine; DNA hypomethylation; CT antigen
New agents for AML and MDS
Keywords: کلوفارابین; acute myeloid leukaemia (AML); myelodysplastic syndromes (MDS); FMS-like tyrosine kinase receptors (FLT3 inhibitors); farnesyl transferase inhibitor (FTI); clofarabine; histone deacetylase (HDAC); DNMT; mTOR; parthenolide; PIM kinase;
Clofarabine Acts as Radiosensitizer In Vitro and In Vivo by Interfering With DNA Damage Response
Keywords: کلوفارابین; Clofarabine; Radiotherapy; Nucleoside analogue; Radiosensitizer; DNA damage;
Polyadenylation inhibition by the triphosphates of deoxyadenosine analogues
Keywords: کلوفارابین; RNA processing; Transcription; Polyadenylation inhibition; Nucleoside analogs; Cladribine; Clofarabine; Fludarabine
The potential of clofarabine in MLL-rearranged infant acute lymphoblastic leukaemia
Keywords: کلوفارابین; Infant ALL; MLL; Paediatric leukaemia; Clofarabine; Epigenetic;
Comparison of fast liquid chromatography/tandem mass spectrometric methods for simultaneous determination of cladribine and clofarabine in mouse plasma
Keywords: کلوفارابین; Ultra performance liquid chromatography; Atmospheric pressure chemical ionization; Photoionization; Cladribine; Clofarabine
New agents for the treatment of acute myeloid leukemia
Keywords: کلوفارابین; acute myeloid leukemia; gemtuzumab ozogamicin; zosuquidar; farnesyltransferase inhibitors; FLT3-targeted tyrosine kinase inhibitors; Bcl-2 antisense; Cloretazine; clofarabine; rapamycin